Researchers at the ICR show that triple drug combinations could prevent resistance in many cancer types.

Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals.

A ring of proteins that holds our chromosomes together as they replicate also plays a vital role in stopping DNA damage from leading to cancer, according to new research.